HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,947,230 | -10.4% | 166,859 | -14.8% | 0.00% | 0.0% |
| Q2 2023 | $16,673,988 | +13.3% | 195,842 | +10.1% | 0.00% | 0.0% |
| Q1 2023 | $14,721,970 | -24.8% | 177,909 | -28.5% | 0.00% | -25.0% |
| Q4 2022 | $19,568,356 | +88.1% | 248,803 | +77.0% | 0.00% | +100.0% |
| Q3 2022 | $10,405,000 | +65.4% | 140,551 | +45.6% | 0.00% | +100.0% |
| Q2 2022 | $6,291,000 | -21.4% | 96,517 | -23.8% | 0.00% | -50.0% |
| Q1 2022 | $8,005,000 | +29.5% | 126,630 | +8.7% | 0.00% | +100.0% |
| Q4 2021 | $6,180,000 | -15.2% | 116,519 | +12.9% | 0.00% | -50.0% |
| Q3 2021 | $7,287,000 | +50.9% | 103,222 | +42.4% | 0.00% | +100.0% |
| Q2 2021 | $4,830,000 | -62.6% | 72,469 | -37.8% | 0.00% | -66.7% |
| Q1 2021 | $12,930,000 | -9.9% | 116,478 | -3.6% | 0.00% | -25.0% |
| Q4 2020 | $14,345,000 | +14.0% | 120,800 | -16.2% | 0.00% | 0.0% |
| Q3 2020 | $12,583,000 | -6.6% | 144,215 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $13,478,000 | -83.4% | 150,486 | -81.5% | 0.00% | -86.2% |
| Q1 2020 | $80,998,000 | +104.6% | 812,740 | +135.9% | 0.03% | +190.0% |
| Q4 2019 | $39,593,000 | -1.4% | 344,587 | +8.2% | 0.01% | -16.7% |
| Q3 2019 | $40,173,000 | +14.0% | 318,482 | +8.7% | 0.01% | +20.0% |
| Q2 2019 | $35,245,000 | +86.6% | 292,872 | +35.7% | 0.01% | +66.7% |
| Q1 2019 | $18,885,000 | +4.9% | 215,870 | +20.0% | 0.01% | 0.0% |
| Q4 2018 | $18,005,000 | +7.7% | 179,957 | +23.4% | 0.01% | +50.0% |
| Q3 2018 | $16,713,000 | -52.0% | 145,860 | -62.5% | 0.00% | -55.6% |
| Q2 2018 | $34,847,000 | +188.7% | 388,574 | +135.5% | 0.01% | +200.0% |
| Q1 2018 | $12,072,000 | +31.1% | 165,013 | +4.1% | 0.00% | +50.0% |
| Q4 2017 | $9,205,000 | +60.0% | 158,486 | +23.6% | 0.00% | +100.0% |
| Q3 2017 | $5,754,000 | +177.4% | 128,246 | +144.2% | 0.00% | 0.0% |
| Q2 2017 | $2,074,000 | -63.1% | 52,521 | -62.1% | 0.00% | -50.0% |
| Q1 2017 | $5,615,000 | +3.2% | 138,397 | +2.3% | 0.00% | 0.0% |
| Q4 2016 | $5,441,000 | -32.6% | 135,341 | -39.3% | 0.00% | 0.0% |
| Q3 2016 | $8,068,000 | +19.7% | 222,810 | -4.2% | 0.00% | 0.0% |
| Q2 2016 | $6,740,000 | -16.6% | 232,483 | +0.6% | 0.00% | -33.3% |
| Q1 2016 | $8,085,000 | +1167.2% | 231,128 | +1068.1% | 0.00% | – |
| Q4 2015 | $638,000 | -63.8% | 19,787 | -63.7% | 0.00% | -100.0% |
| Q3 2015 | $1,761,000 | +36.9% | 54,502 | +75.4% | 0.00% | – |
| Q2 2015 | $1,286,000 | -82.2% | 31,076 | -80.6% | 0.00% | -100.0% |
| Q1 2015 | $7,206,000 | +1476.8% | 160,421 | +1214.7% | 0.00% | – |
| Q4 2014 | $457,000 | -46.3% | 12,202 | -49.9% | 0.00% | – |
| Q3 2014 | $851,000 | -75.9% | 24,360 | -75.7% | 0.00% | -100.0% |
| Q2 2014 | $3,532,000 | +570.2% | 100,126 | +518.9% | 0.00% | – |
| Q1 2014 | $527,000 | -88.1% | 16,179 | -84.6% | 0.00% | -100.0% |
| Q4 2013 | $4,440,000 | +33.5% | 105,397 | +26.4% | 0.00% | 0.0% |
| Q3 2013 | $3,327,000 | +197.6% | 83,413 | +208.5% | 0.00% | – |
| Q2 2013 | $1,118,000 | -92.7% | 27,038 | -92.8% | 0.00% | -100.0% |
| Q4 2012 | $15,305,000 | +20.7% | 374,757 | +137.1% | 0.01% | +20.0% |
| Q3 2012 | $12,677,000 | +51.9% | 158,072 | +40.3% | 0.01% | +25.0% |
| Q2 2012 | $8,348,000 | +107.8% | 112,640 | +95.3% | 0.00% | +100.0% |
| Q1 2012 | $4,018,000 | – | 57,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |